- Home
- MKZR vs ADIL Comparison
MKZR vs ADIL Comparison
Compare MKZR & ADIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MKZR | ADIL |
|---|---|---|
| Founded | 2012 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.2M | 6.4M |
| IPO Year | N/A | 2017 |
Fundamental Metrics
Financial Performance| Metric | MKZR | ADIL |
|---|---|---|
| Price | $3.66 | $1.76 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $37.50 |
| AVG Volume (30 Days) | 19.3K | ★ 87.8K |
| Earning Date | 02-17-2026 | 03-06-2026 |
| Dividend Yield | ★ 13.54% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.50 | $0.13 |
| 52 Week High | $6.99 | $3.67 |
Technical Indicators
Market Signals| Indicator | MKZR | ADIL |
|---|---|---|
| Relative Strength Index (RSI) | 45.28 | 48.72 |
| Support Level | $3.45 | $0.28 |
| Resistance Level | $4.05 | $3.67 |
| Average True Range (ATR) | 0.19 | 0.21 |
| MACD | 0.03 | -0.09 |
| Stochastic Oscillator | 45.04 | 29.41 |
Price Performance
Historical ComparisonAbout MKZR MacKenzie Realty Capital Inc.
Mackenzie Realty Capital Inc is a company which is a Real estate investment trust (REIT). The company has one reportable segment, income-producing real estate properties which consists of activities related to investing in real estate. It is a real estate investment manager who utilizes an approach to real estate securities, often seeing opportunities that others overlook. Based in Orinda, California, MacKenzie Capital Management has specialized in discounted real estate securities and asset management.
About ADIL Adial Pharmaceuticals Inc
Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is for the treatment of alcohol use disorder. The active ingredient in AD04 is ondansetron, a serotonin-3 antagonist.